Skip to main content

KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression.

Qiao Y, Yee MF, Parikh CN, Ma B, Cao Y, Shih YH, Wu JQ, Ruscetti M, Liang SQ, Xue W
Adv Sci (Weinh). 2026 Jan;13(6):e11312. doi: 10.1002/advs.202511312. Epub 2025 Dec 3. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
256624TREt-Kras(G12D)-PGK-rtTA3An "All-in-One" Sleeping Beauty (SB) transposon vector for doxycycline-inducible expression of oncogenic Kras(G12D).

Antibodies from Article